| Cat.No. : |
IL18RAP-1073H
Optional Service: Optional requirements on this protein
|
| Product Overview : |
Recombinant Human IL18RAP (Accession # O95256), fused with , was produced in Mouse myeloma cell line, NS0-derived. |
| Source : |
Mammalian cells |
| Species : |
Human |
| Tag : |
Fc |
| Predicted N Terminal : |
Phe20 |
| Form : |
Lyophilized from a 0.2 µm filtered solution in PBS. |
| Bio-activity : |
Measured by its ability to inhibit the IL-18-induced response of KG-1 human acute myelogenous leukemia cells in the presence of soluble Recombinant Human IL-18 R alpha/IL-1 R5 Fc Chimera.The ED50 for this effect is typically 2 - 6 µg/mL in the presence of 30 µg/mL of soluble IL-18 R alpha/Fc and 40 ng/mL of human IL-18. |
| Molecular Mass : |
Recombinant Human IL18RAP, Fc Chimera has a calculated MW of 65.1 kDa (monomer). In SDS-PAGE migrates as 90-100 kDa, reducing conditions. |
| Purity : |
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Storage : |
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC). |
| Reconstitution : |
Reconstitute at 100 µg/mL 4 mM HCl containing at least 0.1% human or bovine serum albumin. |
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
